ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W107. A total of 37 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $22,000 | -18.5% | 18,045 | 0.0% | 0.00% | – |
| Q1 2017 | $27,000 | +145.5% | 18,045 | +38.3% | 0.00% | – |
| Q4 2016 | $11,000 | -38.9% | 13,045 | 0.0% | 0.00% | – |
| Q3 2016 | $18,000 | +260.0% | 13,045 | +328.4% | 0.00% | – |
| Q2 2016 | $5,000 | +150.0% | 3,045 | +222.2% | 0.00% | – |
| Q1 2016 | $2,000 | -92.6% | 945 | -88.6% | 0.00% | – |
| Q4 2015 | $27,000 | +58.8% | 8,262 | -15.6% | 0.00% | – |
| Q3 2015 | $17,000 | +88.9% | 9,792 | +179.7% | 0.00% | – |
| Q2 2015 | $9,000 | +50.0% | 3,501 | +34.7% | 0.00% | – |
| Q1 2015 | $6,000 | -77.8% | 2,600 | -42.2% | 0.00% | – |
| Q4 2014 | $27,000 | – | 4,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 1,590,267 | $915,000 | 0.48% |
| ARMISTICE CAPITAL, LLC | 4,382,000 | $2,520,000 | 0.30% |
| DAFNA Capital Management LLC | 333,000 | $192,000 | 0.12% |
| SABBY MANAGEMENT, LLC | 2,434,103 | $1,400,000 | 0.09% |
| Anson Funds Management LP | 1,024,592 | $589,000 | 0.09% |
| Hartford Financial Management Inc. | 18,000 | $10,000 | 0.01% |
| Summit X, LLC | 11,000 | $7,000 | 0.01% |
| SNS Financial Group, LLC | 18,000 | $10,000 | 0.00% |
| DOWLING & YAHNKE LLC | 22,870 | $13,000 | 0.00% |
| A.R.T. Advisors, LLC | 30,005 | $17,000 | 0.00% |